Financial Snapshot
What does Henry Schein's latest financial snapshot show?
Henry Schein’s latest financial snapshot is Mixed. The strongest factor is Q1 2026 sales and adjusted EBITDA growth; the main concern is weaker cash conversion and a large debt load relative to cash.
For the latest verified fiscal period ended 2026-03-28, the view combines growth, profitability, cash generation, balance-sheet capacity, and capital efficiency. That makes it useful for academic financial analysis, and the company’s mission background can be paired with Mission Statement, Vision, & Core Values (2026) of Henry Schein, Inc. (HSIC) when you need strategy context.
Free cash flow deserves deeper analysis first.
Revenue Quality
Are Henry Schein revenue and earnings quality improving?
Mixed. Henry Schein’s sales growth looks stronger, but the clearest divergence is that Q1 2026 GAAP net income was $107M versus $110M in Q1 2025, while Non-GAAP Diluted EPS rose to $132, so adjusted earnings improved faster than GAAP earnings.
Revenue quantity improved, but quality is less clear because part of the growth came from acquisitions and business mix, not just underlying demand. Investors compare revenue durability with operating income, net income, and EPS across matching annual periods to see whether sales growth turns into repeatable profit, better margins, and stronger per-share results.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $34B in Q1 2026, up 63% versus Q1 2025 | Q1 2025 revenue not separately stated in the prompt | Unclear mix of organic and acquired growth; Acentus added scale and raised annual revenue base to over $350M | Growth is strong, but investors still need to separate repeat demand from acquisition-driven expansion |
| Operating Income | Not provided for Q1 2026; Adjusted EBITDA was $11B for full-year 2025 | Not provided for the comparable prior period | Not fully testable from the supplied figures | Operating leverage cannot be confirmed from the available period data |
| Net Income | $107M in Q1 2026 | $110M in Q1 2025 | Did not grow with revenue; operating, tax, interest, or unusual-item effects may be weighing on conversion | Final earnings do not fully confirm the sales step-up |
| Diluted EPS | Non-GAAP Diluted EPS was $132 in Q1 2026; FMP EPS Diluted was $092 for 2026-03-28 | Prior-period diluted EPS not provided in the prompt | Adjusted per-share profit strengthened, but the share-count effect cannot be separated from the supplied data | Shareholders saw better adjusted earnings conversion than GAAP net income suggests |
How durable is Henry Schein's revenue?
The strongest durability signal is Henry Schein serving more than 1M customers globally, which supports repeat purchases. The biggest visibility limit is concentration by acquisition and segment mix, especially since Acentus lifted the base and underlying demand is not fully separated.
- Demand Quality: Recurrence is supported by office-based dental and medical customers and dental laboratories, but the prompt does not break out contract visibility or churn.
- Pricing and Volume: Global Medical Distribution sales increased 17% and Global Technology sales increased 70%, but the prompt does not separate price, volume, or mix.
- Diversification: Henry Schein has broad customer breadth, but segment visibility still matters because acquisition-driven growth and technology-led growth can move differently.
That mix matters for profitability and cash conversion. If you’re using this topic for a paper or case study, a structured Mission Statement, Vision, & Core Values (2026) of Henry Schein, Inc. (HSIC), SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help you organize the business drivers clearly.
Profitability and cash flow
Do Henry Schein, Inc. profits convert into cash flow?
Not well in Q1 2026. Reported profit improved, but operating cash flow was -$97M versus $37M in Q1 2025, so cash did not confirm earnings. Free cash flow was not fully supplied, and the weak conversion points to working-capital pressure.
Henry Schein, Inc. posted stronger profit layers in Q1 2026, with gross profit of $107B, operating income of $18200M, EBITDA of $24900M, and net income of $10700M. Adjusted EBITDA rose to $289M from $259M in Q1 2025, while Non-GAAP Diluted EPS reached $132. For context on the business model, see Henry Schein, Inc. (HSIC): History, Ownership, Mission, How It Works & Makes Money. Cash conversion was weaker because operating cash flow turned negative, and the gap between accounting profit and cash likely reflects working-capital swings rather than core margin collapse. Interest expense of $3900M, net interest income of -$3200M, and income tax expense of $3800M should be read separately from operating performance, while the $11M remeasurement gain on the controlling interest in the US distributor of SIN is a comparability item, not a recurring cash driver.
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | Unavailable; period 2026-03-28 | Unavailable; prior comparable period not supplied | Gross profit was $107B, but no margin percentage was supplied. | Shows product economics, but the margin trend cannot be verified from the supplied data. |
| Operating Margin | Unavailable; period 2026-03-28 | Unavailable; prior comparable period not supplied | Operating income was $18200M and adjusted EBITDA improved to $289M from $259M. | Suggests better earnings power, but scale efficiency cannot be measured without the margin percentage. |
| Net Margin | Unavailable; period 2026-03-28 | Unavailable; prior comparable period not supplied | Net income was $10700M, but interest, tax, and the $11M remeasurement gain affect comparability. | Final profitability looks stronger, but the margin result cannot be confirmed. |
| Operating Cash Flow | -$97M in Q1 2026 | $37M in Q1 2025 | Working-capital movement with net receivables of $172B, inventory of $201B, total payables of $124B, and accrued expenses of $90300M. | Cash conversion weakened, so earnings were not fully turning into operating cash. |
| Free Cash Flow | Unavailable; 2026-03-28 | Unavailable; prior comparable period not supplied | Exact capital expenditure and free cash flow values were not supplied; Free Cash Flow Growth was -14024%. | Reinvestment burden cannot be pinned down, so remaining cash for financing is unclear. |
What most affects Henry Schein, Inc. cash conversion?
Working capital is the main driver. The move to -$97M operating cash flow points to receivables, inventory, payables, and accrued expenses overwhelming reported earnings in the quarter.
- Main Driver: Working-capital swings look temporary in this quarter, but they can stay volatile in a distribution business.
- Evidence Gap: Exact capital expenditure and free cash flow values were not supplied.
- Metric to Monitor: Operating cash flow and inventory turnover next quarter.
Liquidity watch
Can Henry Schein’s balance sheet support its obligations and investment needs?
Henry Schein’s balance sheet looks Mixed. Current assets and scale provide protection, but modest cash relative to debt, plus working-capital pressure and short-term borrowings, are the main financing concerns.
Cash alone does not tell the full story. For Henry Schein, the real test is whether current assets, receivables, inventory, debt service, and refinancing capacity can cover day-to-day obligations without squeezing investment. That makes liquidity, solvency, and asset quality more important than cash by itself. For background on the company, see Henry Schein, Inc. (HSIC): History, Ownership, Mission, How It Works & Makes Money.
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | Cash and Cash Equivalents were $13800M, Cash and Short Term Investments were $13800M, Total Current Assets were $450B, and Total Current Liabilities were $330B. | Mixed | Near-term obligations look coverable, but working-capital use still needs close monitoring. |
| Total and Net Debt | Total Debt was $375B, with Short Term Debt of $108B and Long Term Debt of $233B. No net debt figure was supplied. | Mixed | Leverage is meaningful enough to limit flexibility, even with scale. |
| Debt Service and Refinancing | Interest Expense was $3900M for 2026-03-28. No coverage ratio, maturities, refinancing schedule, or interest rates were supplied. | Mixed | Henry Schein appears able to service debt, but refinancing risk cannot be dismissed. |
| Asset Quality | Total Assets were $1130B, Goodwill was $428B, Intangible Assets were $101B, and Goodwill and Intangible Assets were $529B. Inventory was $201B and Net Receivables were $172B. | Mixed | Heavy receivables, inventory, and intangibles add collection, obsolescence, and impairment risk. |
| Liabilities and Equity | Total liabilities and shareholders’ equity were not fully supplied in the prompt, so only the verified asset and debt figures can be used here. | Mixed | Without the full equity line, investors should focus on whether assets and cash flow continue to support obligations. |
Which balance-sheet risk matters most for Henry Schein?
Working-capital pressure matters most. Henry Schein has current assets above current liabilities, but cash is modest versus debt, and inventory plus receivables tie up capital.
- Current Exposure: Cash and Cash Equivalents were $13800M versus Total Debt of $375B, while Current Assets were $450B and Current Liabilities were $330B.
- Protection: The strongest buffer is the current asset base, which exceeds current liabilities and supports ongoing operations.
- Warning Signal: Watch cash conversion, short-term debt, and whether receivables and inventory keep absorbing more capital.
Capital Efficiency
Is Henry Schein using capital efficiently?
Henry Schein looks Mixed on capital efficiency, and internal cash does not appear fully sufficient for reinvestment needs. ROIC, ROE, and ROA were not supplied, so the main signals come from buybacks, acquisition spending, and weaker operating cash flow.
Return measures should be read alongside leverage, asset intensity, capex, working capital swings, and outside funding needs. For a broader ownership angle, see Exploring Henry Schein, Inc. (HSIC) Investor Profile: Who's Buying and Why?. A company can look efficient on paper but still need cash if inventory, receivables, or growth projects absorb more than operations generate.
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | Not supplied. | ROIC cannot be confirmed without the missing input, so operating margins and capital turnover are the practical checks. | Investors should treat invested capital efficiency as unproven from the supplied data alone. |
| ROE and ROA | Not supplied. | ROE may be helped by leverage, while ROA depends on how much asset base Henry Schein needs to run distribution and specialty platforms. | Shareholder return quality and asset efficiency cannot be judged directly from the provided figures. |
| Maintenance and Growth Investment | Full-year 2025 share repurchases totaled $850M for 121M shares at an average price of $70.47 per share. Q1 2026 share repurchases totaled $125M for 16M shares at an average price of $77.64 per share. Reinvestment includes the Acentus acquisition, which expanded the homecare medical supplies platform to an annual revenue base of over $350M. Technology investment includes Dentrix Ascend opening its MCP layer to integrate AI agents and a custom build platform for dental practices, plus continued investment in 3D printers and intraoral scanners. | Buybacks and acquisitions show both capital return and growth investment; the growth spending is visible, but the maintenance share is not separately disclosed. | Capital is being used to support both shareholder returns and strategic expansion into homecare, software, and equipment-adjacent tools. |
| Internal Funding Capacity | Q1 2026 operating cash flow was -$97M while buybacks still used $125M. Dividend Yield was 0.00%. | Internal funding looks mixed because operations were cash-negative in the quarter even as Henry Schein repurchased shares. | Investment appears partly dependent on balance-sheet flexibility and ongoing cash generation, which can affect leverage and reinvestment room. |
Are Henry Schein's returns on capital sustainable?
Sustainability looks mixed: the strongest support is continued investment in higher-value platforms and products, but negative Q1 2026 operating cash flow and ongoing buybacks could weaken returns if cash generation stays soft.
- Operating Source: Mix, platform expansion, and technology-enabled dental and homecare offerings support capital use.
- Funding Requirement: The largest verified capital need is buybacks plus the Acentus and technology investment program.
- Durability Test: Returns would look weaker if operating cash flow stays negative while repurchases and growth spending continue.
Financial resilience
How resilient is Henry Schein, and which warning signs matter most?
Resilience is Mixed. The main buffer is its broad, diversified operating base across more than 1M customers, 34 countries and territories, and three segments. The most important verified warning sign is Q1 2026 operating cash flow of -$97M, which points to working-capital strain.
Henry Schein can still fund core operations, but resilience weakens if cash conversion stays negative, because debt service and reinvestment become more dependent on working-capital swings. Its scale helps, and the Exploring Henry Schein, Inc. (HSIC) Investor Profile: Who's Buying and Why? page can add ownership context, but investors should watch whether later 2026 quarters restore operating cash flow.
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | Lower margins would reduce operating leverage, earnings, cash flow, and debt capacity. | More than 1M customers globally, operations in 34 countries and territories, three segments, approximately 30,000 cartons shipped daily, and ~1,800 supplier partners globally support diversification. | Watch for weaker revenue growth, margin compression, or continued cash outflow. |
| Working-Capital or Investment Pressure | Receivables, inventory, or capex needs can absorb cash and tighten liquidity. | Scale and operating breadth can support internal funding when conversion normalizes. | Monitor operating cash flow in later 2026 quarters and whether working-capital movements keep cash flow negative. |
| Interest or Refinancing Pressure | Higher interest expense would reduce free cash flow and limit financing flexibility. | Cash And Cash Equivalents were $13800M, giving some liquidity support against obligations. | Track debt and cash movement, especially with Total Debt at $375B, Short Term Debt at $108B, and Interest Expense at $3900M for 2026-03-28. |
Which financial warning signs should investors monitor at Henry Schein?
The two strongest signals are operating cash flow and balance sheet funding pressure. Confirmed deterioration is the Q1 2026 -$97M cash flow; future risk is whether debt, cash, and interest expense stay elevated relative to cash generation.
Negative operating cash flow
Q1 2026 operating cash flow was -$97M versus $37M in Q1 2025, so working-capital pressure is real. The next metric to watch is operating cash flow in later 2026 quarters.
Debt and cash mismatch
Cash And Cash Equivalents were $13800M, but Total Debt was $375B, Short Term Debt was $108B, and Interest Expense was $3900M for 2026-03-28. The next metric is debt and cash movement, not Market Capitalization.
Capital deployment while cash is negative
Henry Schein repurchased $125M of shares in Q1 2026 even though operating cash flow was negative. That matters because buybacks can compete with liquidity if cash generation does not improve.
Mixed Scorecard
What does Henry Schein, Inc.’s financial health mean for investors?
Henry Schein, Inc. earns a Mixed overall rating. The strongest factor is adjusted earnings growth, while the weakest factor is cash conversion. The most important condition for the investment case is whether earnings can keep growing while operating cash flow turns positive.
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Strong | Q1 2026 Total Net Sales were $34B, up 63%, and Non-GAAP Diluted EPS was $132, up 148%. Guidance for $523–$537 EPS and 3%–5% sales growth supports durability. |
| Profitability and Cash | Mixed | Adjusted EBITDA rose to $289M from $259M, but operating cash flow was -$97M. That gap shows earnings improvement is not yet converting cleanly into cash. |
| Balance Sheet and Liquidity | Mixed | Total Current Assets of $450B exceeded Total Current Liabilities of $330B, but Cash And Cash Equivalents of $13800M versus Total Debt of $375B leaves leverage worth watching. |
| Capital Efficiency | Mixed | $850M of buybacks in 2025 and $125M in Q1 2026 lifted per-share results, but no ROIC, ROE, or ROA data were supplied and cash flow stayed negative. |
| Financial Resilience | Mixed | Broad customers, global operations, and segment diversity help, but working-capital swings, debt, and confirmed cyber-related events remain pressure points. |
- What Supports the Thesis: Strong EPS growth, higher EBITDA, and buybacks together support per-share performance.
- What Challenges the Thesis: Negative operating cash flow and heavy debt make cash conversion the main uncertainty.
- What to Monitor: Operating cash flow, Total Debt, and Non-GAAP Diluted EPS versus $523–$537 guidance.
If you’re using this for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help organize the evidence. For more context on ownership and market interest, see Exploring Henry Schein, Inc. (HSIC) Investor Profile: Who's Buying and Why?. Forecasts, scenarios, and valuation work should test whether earnings momentum can outlast cash flow pressure.
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
How do Henry Schein acquisitions affect funding capacity?
Acquisitions can add revenue scale, but they also compete with buybacks, technology spending, and debt service for funding Acentus increased the annual revenue base of the homecare medical supplies platform to over $350M, so investors should watch whether acquired growth improves cash generation
Does zero dividend yield strengthen cash retention?
Dividend Yield was 000%, which means supplied data shows no regular dividend yield That can leave more cash available for acquisitions, technology investment, debt management, and repurchases, but Q1 2026 operating cash flow of -$97M still makes cash conversion the key test
What does customer breadth say about resilience?
Henry Schein serves more than 1M customers globally across dental, medical, laboratory, distribution, specialty, and technology channels That breadth supports revenue resilience, but it does not eliminate working-capital pressure, debt service needs, or the need to convert earnings into operating cash flow
How important is technology mix for cash generation?
Technology can support higher-value services and customer retention, but cash impact depends on adoption, spending needs, and profitability Q1 2026 Global Technology sales increased 70%, while the company continued investing in digital dental technologies, AI-enabled platforms, 3D printers, and intraoral scanners
Which liquidity metric matters most for investors?
Operating cash flow is the most important near-term liquidity signal because it shows whether earnings produce cash In Q1 2026, operating cash flow was -$97M compared to $37M in Q1 2025, due to working-capital movements, so later-quarter recovery matters